short communications under five broad headings: clinical studies,
translational therapeutics, molecular diagnostics, genetics and
genomics, and epidemiology. BJC also commissions a very successful
series of minireviews on highly topical subjects.
Click here to read two free sample issues online:
http://ealerts.nature.com/cgi-bin24/DM/y/ejXj0Xztnp0Hhi0EN50Ee
British Journal of Cancer
4 March 2008, Volume 98, Issue 5
Table of Contents
Review
857 Drug transporters: recent advances concerning BCRP and tyrosine
kinase inhibitors
C Lemos, G Jansen and G J Peters
http://ealerts.nature.com/cgi-bin24/DM/y/ejXj0Xztnp0Hhi0BpLy0EZ
_____________________________________________________________________
Clinical Studies
863 Long-term outcomes of high-risk human papillomavirus infection
support a long interval of cervical cancer screening
Y-K Huang, S-L You, C-C Yuan, Y-M Ke, J-M Cao, C-Y Liao,
C-H Wu, C-S Hsu, K-F Huang, C-H Lu, N-F Twu and T-Y Chu
http://ealerts.nature.com/cgi-bin24/DM/y/ejXj0Xztnp0Hhi0BpLz0Ea
_____________________________________________________________________
870 Second malignancies after breast cancer: the impact of
different treatment modalities
Y M Kirova, Y De Rycke, L Gambotti, J-Y Pierga, B Asselain
and A Fourquet
http://ealerts.nature.com/cgi-bin24/DM/y/ejXj0Xztnp0Hhi0BpL10EN
_____________________________________________________________________
875 Early detection of recurrence by 18FDG-PET in the follow-up of
patients with colorectal cancer
I Sobhani, E Tiret, R Lebtahi, T Aparicio, E Itti, F
Montravers, C Vaylet, P Rougier, T André, J M Gornet, D
Cherqui, C Delbaldo, Y Panis, J N Talbot, M Meignan and D
Le Guludec
http://ealerts.nature.com/cgi-bin24/DM/y/ejXj0Xztnp0Hhi0BpL20EO
_____________________________________________________________________
881 Weekly full-dose gemcitabine and single-dose cisplatin with
concurrent radiotherapy in patients with locally advanced
pancreatic cancer
S P Hong, J Y Park, T J Jeon, S Bang, S W Park, J B Chung,
M-S Park, J Seong, W J Lee and S Y Song
http://ealerts.nature.com/cgi-bin24/DM/y/ejXj0Xztnp0Hhi0BpL30EP
_____________________________________________________________________
888 The relationship between quality of life (EORTC QLQ-C30) and
survival in patients with gastro-oesophageal cancer
M McKernan, D C McMillan, J R Anderson, W J Angerson and R
C Stuart
http://ealerts.nature.com/cgi-bin24/DM/y/ejXj0Xztnp0Hhi0BpL40EQ
_____________________________________________________________________
894 A phase I trial of ispinesib, a kinesin spindle protein
inhibitor, with docetaxel in patients with advanced solid
tumours
S P Blagden, L R Molife, A Seebaran, M Payne, A H M Reid,
A S Protheroe, L S Vasist, D D Williams, C Bowen, S J
Kathman, J P Hodge, M M Dar, J S de Bono and M R Middleton
http://ealerts.nature.com/cgi-bin24/DM/y/ejXj0Xztnp0Hhi0BpL50ER
_____________________________________________________________________
900 Population pharmacokinetic data analysis of three phase I
studies of matuzumab, a humanised anti-EGFR monoclonal
antibody in clinical cancer development
K Kuester, A Kovar, C Lüpfert, B Brockhaus and C Kloft
http://ealerts.nature.com/cgi-bin24/DM/y/ejXj0Xztnp0Hhi0BpL60ES
_____________________________________________________________________
907 Multicentre prospective phase II trial of gefitinib for
advanced non-small cell lung cancer with epidermal growth
factor receptor mutations: results of the West Japan
Thoracic Oncology Group trial (WJTOG0403)
K Tamura, I Okamoto, T Kashii, S Negoro, T Hirashima, S
Kudoh, Y Ichinose, N Ebi, K Shibata, T Nishimura, N
Katakami, T Sawa, E Shimizu, J Fukuoka, T Satoh and M
Fukuoka
http://ealerts.nature.com/cgi-bin24/DM/y/ejXj0Xztnp0Hhi0BpL70ET
_____________________________________________________________________
Translational Therapeutics
915 Growth inhibition of non-small cell lung cancer cells by AP-1
blockade using a cJun dominant-negative mutant
Y Shimizu, I Kinoshita, J Kikuchi, K Yamazaki, M
Nishimura, M J Birrer and H Dosaka-Akita
http://ealerts.nature.com/cgi-bin24/DM/y/ejXj0Xztnp0Hhi0BpL80EU
_____________________________________________________________________
923 Inhibition of mTOR pathway by everolimus cooperates with EGFR
inhibitors in human tumours sensitive and resistant to
anti-EGFR drugs
R Bianco, S Garofalo, R Rosa, V Damiano, T Gelardi, G
Daniele, R Marciano, F Ciardiello and G Tortora
http://ealerts.nature.com/cgi-bin24/DM/y/ejXj0Xztnp0Hhi0BpMA0Ee
_____________________________________________________________________
931 Combined expression of caveolin-1 and an activated AKT/mTOR
pathway predicts reduced disease-free survival in
clinically confined renal cell carcinoma
L Campbell, B Jasani, K Edwards, M Gumbleton and D F R
Griffiths
http://ealerts.nature.com/cgi-bin24/DM/y/ejXj0Xztnp0Hhi0BpMB0Ef
_____________________________________________________________________
941 Double inhibition of XIAP and Bcl-2 axis is beneficial for
retrieving sensitivity of renal cell cancer to apoptosis
V Bilim, K Yuuki, T Itoi, A Muto, T Kato, A Nagaoka, T
Motoyama and Y Tomita
http://ealerts.nature.com/cgi-bin24/DM/y/ejXj0Xztnp0Hhi0BpMC0Eg
_____________________________________________________________________
Molecular Diagnostics
950 Cortactin expression predicts poor survival in laryngeal
carcinoma
J H Gibcus, M F Mastik, L Menkema, G H de Bock, Ph M
Kluin, Ed Schuuring and J E van der Wal
http://ealerts.nature.com/cgi-bin24/DM/y/ejXj0Xztnp0Hhi0BpMD0Eh
_____________________________________________________________________
956 Prognostic significance of cortactin levels in head and neck
squamous cell carcinoma: comparison with epidermal growth
factor receptor status
P Hofman, C Butori, K Havet, V Hofman, E Selva, N Guevara,
J Santini and E Van Obberghen-Schilling
http://ealerts.nature.com/cgi-bin24/DM/y/ejXj0Xztnp0Hhi0BpME0Ei
_____________________________________________________________________
965 Hypoxia-associated markers in gastric carcinogenesis and
HIF-2alpha in gastric and gastro-oesophageal cancer
prognosis
E A Griffiths, S A Pritchard, S M McGrath, H R Valentine,
P M Price, I M Welch and C M L West
http://ealerts.nature.com/cgi-bin24/DM/y/ejXj0Xztnp0Hhi0BpMF0Ej
_____________________________________________________________________
974 Laminin-332 promotes the invasion of oesophageal squamous cell
carcinoma via PI3K activation
Y Baba, K-i Iyama, K Hirashima, Y Nagai, N Yoshida, N
Hayashi, N Miyanari and H Baba
http://ealerts.nature.com/cgi-bin24/DM/y/ejXj0Xztnp0Hhi0BpMG0Ek
_____________________________________________________________________
981 Noncoding human Y RNAs are overexpressed in tumours and
required for cell proliferation
C P Christov, E Trivier and T Krude
http://ealerts.nature.com/cgi-bin24/DM/y/ejXj0Xztnp0Hhi0BpMH0El
_____________________________________________________________________
Epidemiology
989 Low-dose aspirin and breast cancer risk: results by tumour
characteristics from a randomised trial
S M Zhang, N R Cook, J E Manson, I-M Lee and J E Buring
http://ealerts.nature.com/cgi-bin24/DM/y/ejXj0Xztnp0Hhi0BpMI0Em
_____________________________________________________________________
992 Parity and breastfeeding are protective against breast cancer
in Nigerian women
D Huo, C A Adebamowo, T O Ogundiran, E E Akang, O
Campbell, A Adenipekun, S Cummings, J Fackenthal, F
Ademuyiwa, H Ahsan and O I Olopade
http://ealerts.nature.com/cgi-bin24/DM/y/ejXj0Xztnp0Hhi0BpMJ0En
_____________________________________________________________________
997 Association of colorectal adenoma with other malignancies in
Swedish families
E Hiripi, J Lorenzo Bermejo, J Sundquist and K Hemminki
http://ealerts.nature.com/cgi-bin24/DM/y/ejXj0Xztnp0Hhi0BpMK0Eo
_____________________________________________________________________
1001 Family history of cancer as a risk factor for second
malignancies after Hodgkin's lymphoma
A Andersson, G Enblad, B Tavelin, M Björkholm, J
Linderoth, I Lagerlöf, M Merup, M Sender and B Malmer
http://ealerts.nature.com/cgi-bin24/DM/y/ejXj0Xztnp0Hhi0BpML0Ep
_____________________________________________________________________
1006 Population mixing, socioeconomic status and incidence of
childhood acute lymphoblastic leukaemia in England and
Wales: analysis by census ward
C A Stiller, M E Kroll, P J Boyle and Z Feng
http://ealerts.nature.com/cgi-bin24/DM/y/ejXj0Xztnp0Hhi0BpMM0Eq
_____________________________________________________________________
1012 Educational differences in cancer mortality among women and
men: a gender pattern that differs across Europe
G Menvielle, A E Kunst, I Stirbu, B H Strand, C Borrell, E
Regidor, A Leclerc, S Esnaola, M Bopp, O Lundberg, B
Artnik, G Costa, P Deboosere, P Martikainen and J P
Mackenbach
http://ealerts.nature.com/cgi-bin24/DM/y/ejXj0Xztnp0Hhi0BpMN0Er
_____________________________________________________________________
Book Review
1020 Radiation Oncology Physics: A Handbook for Teachers and Students
I Rosenberg
http://ealerts.nature.com/cgi-bin24/DM/y/ejXj0Xztnp0Hhi0BpMO0Es
_____________________________________________________________________
======================================================================
You have been sent this Table of Contents Alert because you have opted in to receive it.
You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at:
http://www.nature.com/myaccount
(You will need to log in to be recognised as a nature.com registrant).
For further technical assistance, please contact our registration department:
registration@nature.com
For print subscription enquiries, please contact our subscription department:
subscriptions@nature.com
For other enquiries, please contact customer feedback department:
feedback@nature.com
Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA
Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne -
San Diego - San Francisco - Washington - New York - Boston
Macmillan Publishers Limited is a company incorporated in England and
Wales under company number 785998 and whose registered office is located
at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.
(c) Copyright 2008 Nature Publishing Group
======================================================================
